Eighty-one cases with evidenced MYO15A variants from the 2263 Chinese NSHL cases, who underwent next-generation sequencing (NGS), were enrolled in the study. This evidence concerns the gene MYO15A and nodular sclerosis classical Hodgkin lymphoma.